These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7546535)

  • 1. [Pharmacologic profile of n-palmitoylglycine. Its effect on reserpine and haloperidol catalepsy].
    Vamvakidès A
    Boll Chim Farm; 1995 May; 134(5):258-62. PubMed ID: 7546535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of glycine linoleamide on haloperidol and reserpine catalepsy in the rat].
    Vamvakidès A
    Agressologie; 1986 May; 27(6):481-3. PubMed ID: 3777342
    [No Abstract]   [Full Text] [Related]  

  • 4. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dextromethorphan on dopamine dependent behaviours in rats.
    Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
    Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some pharmacologic comments on the action of glycine derivatives in relation to peculiarities of the central glycinergic system].
    Vamvakidès A
    Agressologie; 1989 Sep; 30(8):465-6. PubMed ID: 2558584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.
    Chartoff EH; Ward RP; Dorsa DM
    J Pharmacol Exp Ther; 1999 Nov; 291(2):531-7. PubMed ID: 10525068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK506 as effective adjunct to L-dopa in reserpine-induced catalepsy in rats.
    Singh A; Naidu PS; Kulkarni SK
    Indian J Exp Biol; 2003 Nov; 41(11):1264-8. PubMed ID: 15332494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting resistance to haloperidol-induced catalepsy in male rats chronically treated with caffeine.
    Góngora-Alfaro JL; Moo-Puc RE; Villanueva-Toledo JR; Alvarez-Cervera FJ; Bata-García JL; Heredia-López FJ; Pineda JC
    Neurosci Lett; 2009 Oct; 463(3):210-4. PubMed ID: 19654037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanolic extract of Rubia peregrina L. (Rubiaceae) inhibits haloperidol-induced catalepsy and reserpine-induced orofacial dyskinesia.
    Maxia A; Frau MA; Foddis C; Lancioni MC; Kasture V; Kasture S
    Nat Prod Res; 2012; 26(5):438-45. PubMed ID: 22316173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
    Khisti RT; Mandhane SN; Chopde CT
    Indian J Exp Biol; 1997 Dec; 35(12):1297-301. PubMed ID: 9567763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of glutamic acid palmitamide or linoleamide on convulsions induced by pentetrazole].
    Vamvakidès A
    Agressologie; 1989 Sep; 30(8):469-71. PubMed ID: 2558585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [D-cycloserine is active in the adult mouse and inactive in the aged mouse, in the forced swim test].
    Vamvakides A
    Ann Pharm Fr; 1998; 56(5):209-12. PubMed ID: 9805820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On some central effects of elymoclavine.
    Roussinov K; Georgiev V; Petkov V; Lazarova M; Petkova B; Shopova S; Markovska V; Getova D; Draganova S
    Acta Physiol Pharmacol Bulg; 1984; 10(4):28-35. PubMed ID: 6442955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurosteroid 3 alpha-hydroxy-5 alpha-pregnan-20-one affects dopamine-mediated behavior in rodents.
    Khisti RT; Deshpande LS; Chopde CT
    Psychopharmacology (Berl); 2002 May; 161(2):120-8. PubMed ID: 11981591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of GABA-linoleamide and glycine-linoleamide on catalepsy in the rat after chronic administration of reserpine].
    Vamvakidès A
    Agressologie; 1986 Nov; 27(10):835-7. PubMed ID: 3028195
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist.
    Ossowska K; Pietraszek M; Wardas J; Wolfarth S
    Pol J Pharmacol; 2004; 56(3):295-304. PubMed ID: 15215559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.